Etelcalcetide Case Report Published in CEN Case Reports

A new publication involving etelcalcetide appeared on October 9, 2026, in the journal CEN Case Reports. The article is titled "Regression of uremic tumoral calcinosis following the switch from cinacalcet to etelcalcetide in a hemodialysis patient without severe hyperphosphatemia." It is listed as a case report concerning a hemodialysis patient who was switched from cinacalcet to etelcalcetide. The publication record does not provide additional details about study design, methodology, or outcomes beyond the title itself. No efficacy or safety conclusions are stated here beyond what the title describes. Etelcalcetide remains an approved compound, and this entry reflects only the existence and indexing of this new case report. Readers interested in the full findings should consult the original source directly, as this brief does not summarize or interpret the content of the case report. For general background on etelcalcetide, including its regulatory status and typical use, readers can refer to the compound overview.